Activating FGFR2-RAS-BRAF mutations in ameloblastoma.
Brown NA, Rolland D, McHugh JB, Weigelin HC, Zhao L, Lim MS, Elenitoba-Johnson KS, Betz BL.
Brown NA, et al. Among authors: weigelin hc.
Clin Cancer Res. 2014 Nov 1;20(21):5517-26. doi: 10.1158/1078-0432.CCR-14-1069. Epub 2014 Jul 3.
Clin Cancer Res. 2014.
PMID: 24993163